Skip to main content
Bon Natural Life Ltd logo

Bon Natural Life Ltd — Investor Relations & Filings

Ticker · BON ISIN · KYG144921056 US Manufacturing
Open in API
Filings indexed 143 across all filing types
Latest filing 2026-03-19 Board/Management Inform…
Country US United States of America
Listing US BON

About Bon Natural Life Ltd

https://www.bnlus.com/

Bon Natural Life Ltd. is a developer and manufacturer of functional active ingredients derived from natural plant extracts. The company engages in the research, development, production, and sale of these compounds for application in the personal care, cosmetic, food, and dietary supplement sectors. Its product portfolio includes plant-extracted fragrance compounds supplied to perfume and fragrance manufacturers, as well as a range of natural health supplements. The company emphasizes innovation, developing proprietary technologies and delivery systems to enhance the bioavailability and efficacy of its ingredients, such as its glucoraphanin-based sleep health product line.

Recent filings

Filing Released Lang Actions
6-K - Bon Natural Life Ltd (0001816815) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Bon Natural Life Limited. It reports the resignation of the Chief Technology Officer and the appointment of a new CTO, including details about the new appointee and an employment agreement. The document includes an exhibit of the employment agreement. There are no financial statements or detailed financial data presented. The content focuses on management changes, specifically the appointment and resignation of senior management personnel. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4586 characters, which is consistent with a typical management change announcement rather than a full report or earnings release.
2026-03-19 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, BON Natural Life Limited. It reports a Framework Cooperation Agreement entered into by a subsidiary, describing the terms and strategic collaboration plans. The document includes exhibits and a signature page. It does not contain financial statements or detailed financial performance data. The length is 4474 characters, which is relatively short and the document primarily announces a cooperation agreement rather than providing a full report or detailed financial data. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement or compliance document that does not fit into more specific categories like Annual Report or Interim Report. It is not a report publication announcement since it contains substantive information about the agreement itself, not just a notice of report availability.
2026-02-17 English
20-F
Annual Report FY 2025
2026-01-22 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, BON NATURAL LIFE LIMITED, for the month of December 2025. It contains a detailed description of a Sales Cooperation Agreement entered into by a subsidiary, including terms, responsibilities, penalties, and legal jurisdiction. The document also includes exhibits such as the agreement translation and a press release. Form 6-K filings are used by foreign private issuers to report material information that is not required to be filed on Forms 20-F or 40-F. This document is not an annual report, earnings release, or other financial report but rather a regulatory filing to disclose a material contract and related information. The length is under 5,000 characters, but the content is substantive and not merely an announcement of a report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-12-10 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, BON NATURAL LIFE LIMITED. It reports a Sales Cooperation Agreement entered into by a subsidiary, including detailed terms of the agreement. The document includes exhibits such as the agreement translation and a press release. Form 6-K filings are periodic reports for foreign private issuers to disclose material information that is not required in annual reports. This document is not an annual report, earnings release, or other financial statement but a regulatory filing to disclose a material contract and related information. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 5108 characters, which is sufficient to contain substantive information rather than just an announcement. Hence, the classification is RNS with high confidence.
2025-11-25 English
6-K
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Bon Natural Life Limited, with the SEC. The content focuses on the resignation of the previous CFO and the appointment of a new CFO, including details about the new CFO's background and employment agreement. There are no financial statements or detailed financial performance data presented. The document is primarily an announcement of a management change, specifically at the senior management level. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 4533 characters, which is sufficient to contain substantive information about the management change but does not contain financial reports or earnings data. Therefore, the appropriate classification is MANG with high confidence.
2025-11-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.